- Home
- CWST vs RYTM Comparison
CWST vs RYTM Comparison
Compare CWST & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CWST | RYTM |
|---|---|---|
| Founded | 1975 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 6.4B |
| IPO Year | 1997 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CWST | RYTM |
|---|---|---|
| Price | $98.77 | $105.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 13 |
| Target Price | $118.67 | ★ $128.31 |
| AVG Volume (30 Days) | ★ 1.5M | 965.1K |
| Earning Date | 02-11-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 102.54 | N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $1,795,272,000.00 | $174,334,000.00 |
| Revenue This Year | $20.40 | $47.34 |
| Revenue Next Year | $7.63 | $55.95 |
| P/E Ratio | $411.24 | ★ N/A |
| Revenue Growth | 20.54 | ★ 54.92 |
| 52 Week Low | $82.22 | $45.91 |
| 52 Week High | $121.24 | $122.20 |
Technical Indicators
Market Signals| Indicator | CWST | RYTM |
|---|---|---|
| Relative Strength Index (RSI) | 52.39 | 43.72 |
| Support Level | $98.14 | $106.00 |
| Resistance Level | $102.51 | $114.19 |
| Average True Range (ATR) | 2.01 | 4.45 |
| MACD | -0.44 | -0.88 |
| Stochastic Oscillator | 18.09 | 3.39 |
Price Performance
Historical ComparisonAbout CWST Casella Waste Systems Inc.
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.